<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.46624/ajptr.2020.v10.i1.014</article-id>
      <article-id pub-id-type="publisher-id">AJPTR101014</article-id>
      <title-group>
        <article-title>Myocardial Infraction: Etiology, Risk Factors, Pathophysiology, Diagnosis and Management</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Khadse</surname>
            <given-names>Neha A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wankhade</surname>
            <given-names>Anjali M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gaiki</surname>
            <given-names>Ajit G.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Pharmaceutical Quality Assurance, Sinhgad Institute of Pharmacy, Savitribai Phule University, Narhe, Pune (MH), INDIA 411041.</aff>
      <pub-date pub-type="epub" iso-8601-date="2020-02-01">
        <month>02</month>
        <day>01</day>
        <year>2020</year>
      </pub-date>
      <volume>10</volume>
      <issue>1</issue>
      <abstract>
        <p>Cardiovascular disease is considered the major cause of morbidity and mortality throughout the world. Also myocardial infraction is the main health problem. In 2015, about 15.9 million myocardial infraction occurred throughout the world. In the United States about one million people have an MI each year. Modifiable risk factors include high blood pressure, smoking, diabetes, lack of exercise, obesity, depression, high blood cholesterol, poor diet, life style and excessive alcohol intake. Family history is also responsible for cardiovascular disease. Reperfusion injury include coronary thrombus formation followed by thrombolytic therapy.  By the physical examination with electrocardiogram findings and cardiac markers MI is diagnosed. Therapeutic intervention such as pharmacologic, non-pharmacologic and combination therapy improves the clinical outcomes in MI patient. This review focus on the risk factors, pathophysiology in relation to produce myocardial injury and on the cardioprotective treatment.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Myocardial infraction</kwd>
        <kwd>Pathophysiology</kwd>
        <kwd>risk factors</kwd>
        <kwd>Cardiac injury</kwd>
        <kwd>Management.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
